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Dilatation of the renal pelvis is one of the most common fetal anomalies diagnosed with an ultrasound examination performed in the antenatal period. It is reported that 
it is observed in approximately 1–5% of all pregnancies [1-3]. 
Dilatation of the renal pelvis can be unilateral or bilateral. 
However, it is more commonly unilateral [2,4,5]. It is 2.5 times 
more common in males than females [6]. Various classification 
systems are used for the diagnosis of renal pelvic dilatation in 
the fetus in the antenatal period [7]. The most commonly used 
parameter for the diagnosis of renal pelvic dilatation is the 
measurement of anteroposterior diameter (APD) of the renal 
pelvis in the transverse plane [8].
MATERIALS AND METHODS
This study was conducted between July 2017 and February 2018 
at the perinatology and pediatric surgery clinic of a tertiary care 
hospital. Infants were included in this study if they were consulted 
with the pediatric surgery clinic due to the diagnosis of renal pelvic 
dilatation detected on maternal ultrasonographic examination. 
These were detected when their mothers were screened for 
detecting fetal anomalies by measuring the APD of the renal pelvis 
in the transverse plane with an ultrasonographic examination.
The measurement of APD of the renal pelvis in the transverse 
plane was performed using a GE Voluson E6 BT 17 (Zipf Austria) 
ultrasound device by the same physician who was a perinatal 
specialist. The fetuses were included in the evaluation if they 
had an APD of the renal pelvis of at least 5 mm measured in the 
transverse plane with ultrasonography. The results were classified 
as mild, moderate, or severe based on the measurements of the 
APD of the kidney in the transverse plane [9].
RESULTS
A renal pelvic dilatation was detected by evaluating the APD of 
the renal pelvis in the transverse plane with ultrasonography in 
69 (1.6%) fetuses of 4216 pregnant women screened for detecting 
fetal anomalies. The median age of screened pregnant women 
was 28.7 years. The fetal anomaly screening was performed in 
the second and third trimesters of pregnancies in 47 (68.1%) 
and 22 pregnant women (31.9%), respectively. The renal pelvic 
dilatation was unilateral in 50% of the fetuses, and it was bilateral 
in the remaining 50%. The ultrasound examination performed 
for monitoring purposes in the postnatal period showed that the 
dilatation of the renal pelvis regressed or resolved in 82.7% (n=57) 
of the infants who were diagnosed with a renal pelvic dilatation in 
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the antenatal period during the screening of the pregnant women 
for fetal anomalies.
The renal pelvic dilatation persisted in 17.3% (n=12) of 
the infants with renal pelvic dilatation during the follow-up 
period. When the results of the measurements of the renal pelvic 
dilatations in 47 fetuses who were diagnosed during the pregnancy 
screening in the 2nd trimester were classified, it was found out that 
the renal pelvic dilatation was mild in 41 (87.2%) of the fetuses, it 
was moderate in 5 (7.2%) fetuses, and it was severe in one (1.4%) 
fetus. Of the 22 fetuses diagnosed in the third trimester, 17 were 
classified as mild, 3 (13.6%) were classified as moderate, and 
2 (9%) were classified as severe.
In addition to the dilatation of the renal pelvis, infants with 
renal pelvic dilatation were found to have other anomalies 
including ventricular septal defect in two infants, omphalocele in 
one infant, choroid plexus cyst in one infant, and rocker bottom 
foot in one infant. In addition, of the infants diagnosed with renal 
pelvic dilatation, two had a unilateral polycystic kidney, two had 
a unilateral renal agenesis, and two had a unilateral bifid pelvis. 
Of the 11 patients who were followed up in the postnatal period, 
three infants underwent a pyeloplasty. The other patients are still 
being followed up.
DISCUSSION
In our study performed in our clinic, the incidence of renal pelvic 
dilatation in the fetuses was found to be 1.6% in the population 
of pregnant women who underwent screening to detect fetal 
anomalies. In the studies reported in the literature, the rate of 
detection of the renal pelvic dilatation was 1––4.5% during the 
screenings performed in populations of pregnant women for 
the detection of fetal anomalies. In the literature, the diagnosis 
of the dilatation of the renal pelvis is categorized into three 
groups based on the measurements of the APD of the renal pelvis 
in the transverse plane by ultrasonography. According to this 
classification, in the second trimester, measuring a diameter of 
5–6 mm constitutes the mild-risk group, 7–10 mm the moderate-
risk group, and 10 mm the high-risk group; in the third trimester, 
7–9 mm constitutes the mild-risk group, 10–15 mm the moderate-
risk group, and a diameter larger than 15 mm the high-risk group.
Several studies are available in the literature reporting that the 
rate of identifying renal pelvic dilatation reaches up to 18% in 
the pregnant population when the cutoff value is 3 mm for the 
diagnosis of renal pelvic dilatation [13,14]. Chudleigh et al. found 
an incidence of 0.7% and all cases were considered to be in the 
low-risk group [14]. In regard to the prevalence of renal pelvic 
dilatation, Ahmad et al. reported similar findings in pregnant 
women. The results of our study are in the range of figures 
reported for the incidence of identifying renal pelvic dilatation 
reported in the literature [15]. The different results in the observed 
frequencies of this finding in the literature are due to the different 
cutoff values.
The accepted cutoff value was 5 mm in our study. There are 
studies in the literature that accept similar cutoff values [10-12,15]. 
The UK Fetal Medical Association advocates a 5-mm cutoff 
value. The UK National Health Screening Program describes 
the values above 7 mm as renal pelvic dilatation [15]. There is a 
divergence in the opinions of radiologists and pediatric urologists 
in the evaluation of renal pelvic dilatation. A multidisciplinary 
summit was held in the US in 2014 on diagnosing the renal 
pelvic dilatation, describing the cutoff value as 4 mm in the 
16–27th weeks of pregnancy similar to the results of the Society 
for Fetal Urology [7]. However, the specificity of a cutoff value 
of 4 mm is relatively lower in identifying renal pelvic dilatation, 
leading to unnecessary concerns in the future mothers and their 
families.
A renal pelvic dilatation was identified in 1.6% of the pregnant 
women included in our study. Of the fetuses diagnosed with a 
dilatation of the renal pelvis, only 14.4% were in the moderate - and 
severe-risk groups. In our study, it was determined that the renal 
pelvic dilatation was regressed or resolved in 82.7% of the 
infants in the mild-risk group as observed in the ultrasonographic 
examinations performed for monitoring purposes. The results 
are consistent with our results [15]. The results of a multicenter 
study conducted by Longpre et al. in 2012 and of a large-scale 
study conducted by Lee et al in 2014 reported similar results 
with those of our study. In our study, only three infants with 
severe renal pelvic dilatation were operated due to the failure 
of regression during the postnatal follow-up examinations. The 
relatively lower rate observed in our study may result from the 
following factors including the retrospective design of our study, 
different follow-up intervals, and conduct of postnatal follow-up 
examinations of the infants in the moderate- and high-risk groups 
at external diagnostic centers.
The following factors are the limitations of our study including 
the relatively shorter follow-up period, the failure to collect the 
results from all pregnant women included in the screening, the 
conduct of the study at a single center, and the failure of having 
ultrasound examinations performed for all infants in the postnatal 
period. In the postnatal period, it is more likely to observe 
regressions in the renal pelvic dilatations in the mild group 
identified by the measurements performed in the third trimester 
of the pregnancy in the antenatal period [15,16].
CONCLUSION
A cutoff value of 5 mm is a valid value for the diagnosis of 
renal pelvic dilatation during the second trimesters. It is critical 
to provide consultations for the parents about further diagnostic 
tests when the renal pelvic dilatation persists.
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